AI assistant
LABCORP HOLDINGS INC. — Director's Dealing 2017
Oct 23, 2017
30237_dirs_2017-10-23_0717128b-b4ed-435d-86ae-68195411dfa4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2017-09-01
Reporting Person: Gary M. Huff (CEO, LabCorp Diagnostics)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-01 | Common Stock | M | 153 | — | Acquired | 400.3653 | Direct |
| 2017-09-01 | Common Stock | F | 51 | $157.61 | Disposed | 349.3653 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-01 | Restricted Stock Unit | $ | M | 153 | Disposed | Common Stock (153) | Direct |
Footnotes
F1: Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: Amount includes 193.3653 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
F3: Stock withholding to satisfy tax withholding obligations.
F4: The Restricted Stock Units vest in three equal annual installments beginning on 9/1/17.
F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.